Macfarlanes has advised Nerano Pharma Limited on the provision of an interest-bearing secured convertible facility to Advanced Oncotherapy plc. Advanced Oncotherapy will use the funding to…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
